Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Tangent screens help detect visual field defects from vigabatrin.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The treatment was not recommended due to limited effectiveness and significant side effects.

Safflower is the most effective in protecting against liver and kidney damage, followed by silymarin and dandelion.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

A woman's hair turned white after taking a cancer drug called dasatinib.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Pranlukast and mirabegron may work as new diabetes drugs.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Divalproex sodium can cause pleural effusion, which stops when the drug is discontinued.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.